Company: STAA
Filing Date: 2025-08-29
Form Type: PREM14A
Source: 0001193125-25-192889
Chunk: 103

Company: STAAR SURGICAL CO
Filing Date: 2025-08-29
Form: PREM14A
Chunk 103
---
 any or all of the assumptions underlying such unaudited prospective financial information are no longer appropriate. Interests of STAAR’s Executive Officers and Directors in the Merger In considering the recommendation of the Board that STAAR stockholders vote for the Merger Proposal and the Compensation Proposal, STAAR stockholders should be aware that the executive officers and directors of STAAR have certain interests in the transactions contemplated by the Merger Agreement that are or may be different from, or in addition to, the interests of STAAR stockholders generally. The Board was aware of these interests and considered them, among other matters, in determining that the Merger Agreement and the transactions contemplated thereby, including the Merger, on the terms and subject to the conditions set forth in the Merger Agreement, are advisable, fair to and in the best interests of STAAR and its stockholders, approving, adopting and declaring advisable the execution and delivery of, and entry into, the Merger Agreement, and directing that the Merger Agreement be submitted to the STAAR stockholders for adoption at the Special Meeting. These interests are described in more detail below, and certain of them are quantified in the narrative below, including compensation that may become payable in connection with the Merger to STAAR’s named executive officers (which is the subject of an advisory (nonbinding) vote of STAAR stockholders). For more information, please see the section of this proxy statement titled “Proposal 2: The Compensation Proposal.” The dates used below to quantify these interests have been selected for illustrative purposes only in accordance with SEC rules and do not necessarily reflect the dates on which certain events will occur. For purposes of this disclosure, STAAR’s named executive officers are:

| • |     | Stephen C. Farrell—Chief Executive Officer |

| • |     | Deborah Andrews—Chief Financial Officer |

| • |     | Warren Foust—President and Chief Operating Officer |

| • |     | Magda Michna, PhD—Chief Development Officer |

| • |     | Nathaniel B. Sisitsky, Esq.—Chief Legal Officer and Corporate Secretary |

| • |     | Thomas G. Frinzi—Former President and Chief Executive Officer |

| • |     | Patrick F. Williams—Former Chief Financial Officer |

For purposes of this disclosure, STAAR’s executive officers consist of its named executive officers, other than Messrs. Frinzi and Williams. Treatment of STAAR Long-Term Incentive Awards STAAR Options. At the Effective Time, each In